AKT1 and hepatocellular carcinoma: An opposite expression trend of these proteins was observed in TXNRD1 overexpression cells when treated with MK2206 (Fig. 4F and Fig. S4E), indicating that the promoting effect of TXNRD1 in HCC proliferation and metastasis was via Akt/mTOR signaling pathway.